Tag: prostate

TUESDAY, Feb. 19, 2019 — Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide versus placebo, according to a phase 3 study published online Feb. 14 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb.

What are the symptoms that indicate a change in the prostate? Prostate cancer is the most common cancer in men. Every year, around 60,000 new cases occur. According to information of the German cancer society every fourth Tumor in men develops in the prostate. Approximately 10 percent of the cases end fatally. Thus, the prostate

Experts from the Universities of Bath and Seville have carried out a series of experiments by which, for the first time, they have characterized the normal electrical activity in PC-3 prostate cancer cells in real time, with a resulting low-frequency electrical pattern between 0.1 and 10 Hertz. “We have observed that this electrical activity evolves

PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men’s initially measured PSA levels proved highly significant as a predictor of future cancer risk. “This research is important, because it shows the long-term effects of an organized

YouTube fueling prostate myths: 77% of 150 most watched videos ‘have factual errors’ There are well over half a million videos about prostate cancer on YouTube  More than 77 percent of the videos included incorrect or biased information about the disease About half of the videos did not describe the recommended ‘shared decision-making’ doctors and

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It’s more common—and more than twice as deadly—among black men compared to their white counterparts. Yet the United States Preventive Services Task Force (USPSTF) recommendations for prostate cancer screening do not differentiate for race,

High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective than the other. For the first time, researchers have shown that more patients live longer if treated with the

(HealthDay)—Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging, according to a study published online Aug. 17 in JAMA Network Open. Danil V. Makarov, M.D., from New York University School of Medicine in New York City, and colleagues examined the correlation between prostate cancer imaging rates and

Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer. At present, the test has limitations for diagnosis and has to be sent off to central labs for the results, a process which can take up

Growing miniature tumors from patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists. Patients with prostate cancer often receive therapies that reduce levels of testosterone. Many of their tumors eventually become resistant to such hormone-reducing

Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease. Every cancer tumor is unique, with characteristics that change over time. This so-called heterogeneity is due to competing clones within a given tumor, as well as

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer. The study suggested a genetic subset of prostate cancer may benefit from this form of immunotherapy. The study

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy. In a newly published study in Journal of

Prostate cancer breakthrough: New DNA test identifies men who are SIX TIMES more likely to develop the disease Researchers identified 63 new genetic mutations linked to the condition  Combined with over 100 variants known to cause the cancer to make the test One in 100 men carry sufficient numbers of genetic variations to put them

A unique bacterial strain isolated from a patient with pelvic pain may represent a promising path to treating prostate cancer with immunotherapy, according to a Northwestern Medicine study published in Nature Communications. The study demonstrated how the bacterial strain travels directly to the prostate and induces low-level inflammation, boosting the effectiveness of immune checkpoint inhibitor

The latest Annual Report to the Nation on the Status of Cancer finds that overall cancer death rates continue to decline in men, women, and children in the United States in all major racial and ethnic groups. Overall cancer incidence, or rates of new cancers, decreased in men and were stable in women from 1999

Researchers have discovered that the Skene glands share some of the same properties as the male prostate, which is located between the bladder and the penis. For example, both the prostate and the Skene glands contain prostate-specific antigen (PSA) and PSA phosphatase (PSAP), which are enzymes that can indicate the health of the prostate in

A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy. Led by Professor Catharine West, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours. The

The National Cancer Institute (NCI) estimate that 164,690 people will be diagnosed with prostate cancer in 2018. They suggest that more than 11 percent of men will receive this diagnosis at some point during their lifetime. Treatments for prostate cancer can include radiation therapy, hormone therapy, and chemotherapy. But unfortunately, in many cases, tumors that